`Patent 7,039,033
`
`
`By: Andy H. Chan, Reg. No. 56,893
`Pepper Hamilton LLP
`333 Twin Dolphin Drive
`Suite 400
`Redwood City, CA 94065
`(650) 802-3602 (telephone)
`(650) 802-3650 (facsimile)
`chana@pepperlaw.com
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`SAMSUNG ELECTRONICS CO., LTD.,
`SAMSUNG ELECTRONICS AMERICA, INC., AND APPLE INC.,
`Petitioner
`v.
`
`IXI IP, LLC
`Patent Owner
`___________________
`
`Case No. IPR2015-01444
`Patent 7,039,033
`___________________
`
`PATENT OWNER’S REPLY IN SUPPORT OF MOTION TO EXCLUDE
`EVIDENCE PURSUANT TO 37 C.F.R. §§ 42.62 AND 42.64(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`TABLE OF CONTENTS
`
`
`IPR2015-01444
`Patent 7,295,532
`
`B.
`
`I.
`II.
`
`Page(s)
`
`Exhibits 1002, 1014 and 1015 Should Be Excluded ...................................... 1
`Exhibits 1016 and 1017 Should Be Excluded ................................................ 2
`Exhibits 1016 and 1017 Are Inadmissible Pursuant to 37 C.F.R
`A.
`§ 42.123(b) ........................................................................................... 2
`Exhibit 1016 is Not Authenticated ....................................................... 3
`1.
`Exhibit 1016 is Not Self-Authenticated ..................................... 3
`2.
`Petitioner’s Declaration Fails to Authenticate Exhibit
`1016 ............................................................................................ 4
`Exhibit 1016 Constitutes Hearsay ........................................................ 4
`C.
`Exhibits 1016 and 1017 Are Not Relevant .......................................... 5
`D.
`III. Conclusion ...................................................................................................... 5
`
`
`i
`
`
`
`
`
`TABLE OF AUTHORITIES
`
`
`IPR2015-01444
`Patent 7,039,033
`
`Page(s)
`
`
`CASES
`Genzyme Therapeutic Prods. L.P. v. Biomarin Pharm. Inc.,
`Nos. 2015-1720, 2015-1721, 2016 U.S. App. LEXIS 10711
`(Fed. Cir. June 14, 2016) .................................................................................. 2, 5
`
`Toshiba Corp. v. Optical Devices, LLC,
`Case IPR2014-01445 (PTAB Mar. 9, 2016) ........................................................ 2
`
`STATUTES
`
`35 U.S.C. § 316(e) ..................................................................................................... 1
`
`OTHER AUTHORITIES
`
`37 C.F.R. § 42.22 ....................................................................................................... 1
`
`37 C.F.R. § 42.24 ....................................................................................................... 1
`
`37 C.F.R. § 42.104 ..................................................................................................... 1
`
`37 C.F.R § 42.123 .................................................................................................. 2, 3
`
`FRE 401 ..................................................................................................................... 1
`
`FRE 402 ..................................................................................................................... 1
`
`FRE 403 ..................................................................................................................... 1
`
`FRE 802 ..................................................................................................................... 4
`
`FRE 803 ..................................................................................................................... 5
`
`FRE 901 ................................................................................................................. 3, 4
`
`FRE 902 ..................................................................................................................... 3
`
`
`
`ii
`
`
`
`
`
`IPR2015-01444
`Patent 7,039,033
`
`EXHIBIT LIST
`
`Description
`
`Declaration Of Dr. Narayan Mandayam In Support Of IXI IP, LLC’s
`Patent Owner Response
`Deposition Transcript of Safye Kiaei, IPR2015-01443, March 15,
`2016
`Deposition Transcript of Safye Kiaei, IPR2015-01444, March 16,
`2016
`Deposition Transcript of Safye Kiaei, IPR2015-01445 – 1446, March
`17, 2016.
`Specification of the Bluetooth System, Specification Volume 1
`(December 1, 1999) (Bluetooth Specification)
`IP Network Address Translator (NAT) Terminology and
`Considerations,” RFC 2663, August 1999
`
`
`
`
`
`Ex. #
`
`2301
`
`2302
`
`2303
`
`2304
`
`2305
`
`2306
`
`
`
`iii
`
`
`
`IPR2015-01444
`Patent 7,039,033
`Petitioner bears the burden to prove a proposition of unpatentability by a
`
`preponderance of the evidence. 35 U.S.C. § 316(e). As discussed below and in
`
`Patent Owner’s Motion, Exhibits 1002, and 1014-1017 should be excluded.
`
`I.
`
`EXHIBITS 1002, 1014 AND 1015 SHOULD BE EXCLUDED
`
`Petitioner does not dispute Patent Owner’s allegation that Exhibits 1002,
`
`1014, and 1015 are inadmissible because they are not referenced or explained in
`
`the Petition or the Reply, in violation of 37 C.F.R. §§ 42.22(a)(2), 42.104(b)(4).
`
`Further, Petitioner does not dispute that these exhibits constitute an improper
`
`attempt to circumvent the page limits for the Petition. See 37 C.F.R.
`
`§42.24(a)(1)(i). As such, for at least these reasons, Exhibits 1002, 1014, and 1015
`
`should be excluded.
`
`Petitioner only challenges Patent Owner’s arguments that Exhibits 1002,
`
`1014, and 1015 are irrelevant and prejudicial. See Paper 24 at 2-3. Petitioner
`
`argues that the exhibits were cited in Dr. Kiaei’s Declaration (Exhibit 1003) and
`
`the relevant paragraphs of his declaration were cited in the Petition. See id.
`
`Petitioner’s citations to Dr. Kiaei’s Declaration do not identify how
`
`Petitioner intends to rely, if at all, on these exhibits. Petitioner’s failure to
`
`reference or explain these exhibits prejudices Patent Owner’s ability to evaluate
`
`their relevancy and prepare rebuttal arguments. As such Exhibits 1002, 1014, and
`
`1015 should be excluded as irrelevant and prejudicial under FRE 401, 402, 403.
`
`
`
`1
`
`
`
`IPR2015-01444
`Patent 7,039,033
`
`II. EXHIBITS 1016 AND 1017 SHOULD BE EXCLUDED
`A. Exhibits 1016 and 1017 Are Inadmissible Pursuant to 37 C.F.R §
`42.123(b)
`
`Patent Owner’s Motion is the proper mechanism to challenge Exhibits 1016
`
`and 1017, first introduced in Petitioner’s Reply. See Genzyme Therapeutic Prods.
`
`L.P. v. Biomarin Pharm. Inc., Nos. 2015-1720, 2015-1721, 2016 U.S. App. LEXIS
`
`10711, at *17 (Fed. Cir. June 14, 2016). A reply does not provide the means for
`
`the Petitioner to supplement the evidence of record. See, e.g., Toshiba Corp. v.
`
`Optical Devices, LLC, Case IPR2014-01445, Paper 31 at 30 (PTAB Mar. 9, 2016).
`
`Contrary to Petitioner’s arguments, Exhibits 1016 and 1017 constitute
`
`improper supplemental evidence, and are not proper reply evidence. See 37 C.F.R.
`
`§ 42.123(b). As explained in Patent Owner’s Motion, Exhibits 1016 and 1017 are
`
`not proper reply evidence because Petitioner uses these exhibits in an attempt to
`
`raise new issues and to rehabilitate its arguments. See Paper 21 at 2-5.
`
`Petitioner argues that Exhibits 1016 and 1017 are proper reply evidence
`
`because they respond to Patent Owner’s arguments that: 1) the JINI LUS must be
`
`located on the master device of the Bluetooth piconet; 2) Marchand’s JINI
`
`technology does not teach plug and play as claimed by the patent at-issue; and 3)
`
`Marchand does not teach that any device can access a webpage. Paper 24 at 4-6.
`
`Petitioner’s arguments fail because for each argument identified, Petitioner
`
`was the first to raise the issue. First, Petitioner’s expert, Dr. Kiaei, was the first to
`
`
`
`2
`
`
`
`IPR2015-01444
`Patent 7,039,033
`identify that the JINI LUS 46 must be located on the master device of the
`
`Bluetooth piconet, not Patent Owner or Dr. Mandayam. Exhibit 2303 at 86:8-12
`
`(“The lookup service is located on the master device.”). Further, Petitioner’s
`
`argument in its Reply regarding multiple JINI LUSs has never been previously
`
`argued, has no basis in any of the alleged prior art or the challenged patent, and
`
`relies entirely on attorney argument. Second, Petitioner argued that Marchand’s
`
`JINI technology taught plug and play in the Petition. See Paper 2 at 42, 43, 50.
`
`Patent Owner’s discussion of Marchand’s JINI technology responded to
`
`Petitioner’s arguments, by identifying why Marchand’s JINI technology does not
`
`teach plug and play as claimed by the ’033 Patent. Third, Patent Owner’s
`
`argument that Marchand does not teach that any device can access a webpage is
`
`also in response to Petitioner’s arguments in the Petition. See Paper 2 at 33.
`
`As such, Exhibits 1016 and 1017 are not proper reply evidence and should
`
`be excluded as improper supplemental evidence pursuant to 37 C.F.R. §42.123(b).
`
`B.
`
`Exhibit 1016 is Not Authenticated
`
`1.
`
`Exhibit 1016 is Not Self-Authenticated
`
`Petitioner asserts that Exhibit 1016 is self-authenticating but makes no
`
`arguments regarding FRE 902, concerning “Evidence That is Self-Authenticating,”
`
`and instead focuses on FRE 901(b)(4), relating to authenticating evidence through
`
`distinctive characteristics. See Paper 24 at 7; FRE 902, 901(b)(4). Petitioner
`
`
`
`3
`
`
`
`IPR2015-01444
`Patent 7,039,033
`asserts that Exhibit 1016 is “distinctive under the circumstances,” but fails to
`
`provide any reasoning as to why this exhibit should be considered distinctive or
`
`how it satisfies the requirements of FRE 901(b)(4). Paper 24 at 7. As such,
`
`Exhibit 1016 is not self-authenticating, and should be excluded for lack of
`
`authentication.
`
`2.
`
`Petitioner’s Declaration Fails to Authenticate Exhibit 1016
`
`After providing nothing in its Reply brief to support the admissibility of
`
`Exhibit 1016, Petitioner relies on a defective declaration from a declarant with no
`
`personal knowledge of the exhibit. See Exhibit 1020.
`
`The Sheldon-Hess Declaration fails to authenticate Exhibit 1016. Ms.
`
`Sheldon-Hess has no personal knowledge of Exhibit 1016 and admits that her
`
`opinions regarding Exhibit 1016 relied on a review of a similar, but different
`
`book—not a review of the reference constituting Exhibit 1016, as proffered by
`
`Petitioner. See Exhibit 1020 at ¶ 9. As such, the Sheldon-Hess Declaration does
`
`not authenticate Exhibit 1016, and it should be excluded under FRE 901.
`
`C. Exhibit 1016 Constitutes Hearsay
`Petitioner does not dispute that the date information appearing on Exhibit
`
`1016, alone, constitutes hearsay under FRE 802. Instead, Petitioner argues that the
`
`information should not be considered hearsay based on the Sheldon-Hess
`
`Declaration. Petitioner argues that the date information qualifies as a hearsay
`
`
`
`4
`
`
`
`IPR2015-01444
`Patent 7,039,033
`exception under FRE 803(6) and (18). Paper 24 at 8. However, Petitioner fails to
`
`explain how FRE 803(6) or (18) applies to this exhibit. Further, Ms. Sheldon-Hess
`
`does not have personal knowledge of Exhibit 1016 and her opinions are
`
`unsupported. See Exhibit 1020 at ¶ 9. As such, Exhibit 1016 constitutes
`
`inadmissible hearsay and should be excluded.
`
`D. Exhibits 1016 and 1017 Are Not Relevant
`Patent Owner’s Motion is the proper mechanism to challenge Petitioner’s
`
`new, unsupported, and irrelevant exhibits. See Genzyme Therapeutic, 2016 U.S.
`
`App. LEXIS 10711 at *17. Petitioner first introduced Exhibits 1016 and 1017 in
`
`its Reply without any support to suggest that these exhibits are relevant.
`
`Petitioner provides only conclusory allegations that Exhibits 1016 and 1017
`
`demonstrate that alleged prior art references teach certain claim elements.
`
`Petitioner fails to provide any substantive detail supporting its allegations and
`
`provides no expert support. Petitioner’s conclusory allegations, based solely on
`
`attorney argument, fail to provide any basis for the conclusion that Exhibits 1016
`
`and 1017 are relevant to any of the facts in-issue.
`
`III. CONCLUSION
`For the foregoing reasons, Exhibits 1002, 1014, 1015, 1016, and 1017
`
`should be excluded.
`
`
`
`
`
`5
`
`
`
`IPR2015-01444
`Patent 7,039,033
`
`Respectfully submitted,
`
` /Andy H. Chan/
`By:
`Andy H. Chan, Reg. No. 56,893
`Pepper Hamilton LLP
`333 Twin Dolphin Drive,
`Suite 400
`Redwood City, CA 94065
`(650) 802-3600 (telephone)
`(650) 802-3650 (facsimile)
`
`George S. Haight IV, Reg. No. 54,146,
`Pepper Hamilton LLP
`125 High Street
`19th Floor High Street Tower
`Boston, MA 02110
`(617) 204-5165 (telephone)
`(617) 204-5150 (facsimile)
`
`Attorneys for Patent Owner
`
`6
`
`
`Dated: August 31, 2016
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2015-01444
`Patent 7,039,033
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on this 31st day of August, 2016, a true and correct copy
`
`of the foregoing Patent Owner’s Reply in Support of Motion to Exclude Evidence
`
`Pursuant to 37 C.F.R. §§ 42.62 and 42.64(c) was served on the following counsel
`
`for Petitioner via email:
`
`W. Karl Renner
`Email: axf@fr.com
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (202) 783-5070
`Fax: (202) 783-2331
`
`
`Kevin Greene
`Email: IPR00035-0004IP1@fr.com
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (202) 783-5070
`Fax: (202) 783-2331
`
`Jeremy Monaldo
`Email: PTABInbound@fr.com
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (202) 783-5070
`Fax: (202) 783-2331
`
`Indranil Mukerji
`Email: PTABInbound@fr.com
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (202) 783-5070
`Fax: (202) 783-2331
`
`
`
`
`7
`
`
`
`IPR2015-01444
`Patent 7,039,033
`
`
`Katherine A. Vidal
`Email: PTABInbound@fr.com
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: 650-839-5084
`Fax: 877-769-7645
`
`
`Respectfully submitted,
`By: /Andy H. Chan/
`
`Andy H. Chan, Reg. No. 56,893
`Pepper Hamilton LLP
`333 Twin Dolphin Drive,
`Suite 400
`Redwood City, CA 94065
`(650) 802-3600 (telephone)
`(650) 802-3650 (facsimile)
`
`
`
`
`
`
`
`
`
`8
`
`
`
`
`
`Dated: August 31, 2016